BioSpace News Archive

Business

Zoetis Announces Second Quarter 2018 Results

Reports Revenue of $1.4 Billion, Growing 12%, and Net Income of $384 Million

August 2, 2018
·
33 min read
Business

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

Aethlon Medical, Inc. announced it will issue financial results for the first quarter fiscal year 2019 ended June 30, 2018 at 4:15pm eastern time on Wednesday, August 8, 2018.

August 2, 2018
·
2 min read
Business

AmerisourceBergen Reports Fiscal 2018 Third Quarter Results

Revenues of $43.1 Billion for the Third Quarter, an 11.5 Percent Increase Year-Over-Year

August 2, 2018
·
43 min read
Business

Encision Reports First Quarter Fiscal Year 2019 Results

Encision Inc. announced financial results for its fiscal 2019 first quarter that ended June 30, 2018.

August 2, 2018
·
15 min read
Business

Novartis announces US renewables agreement to reduce greenhouse gas emissions

Virtual Power Purchase Agreement (VPPA) with renewable energy company, Invenergy, adds 100 megawatts of clean power to the electrical grid.

August 2, 2018
·
6 min read
Business

Concert Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Company Update

Clinical Programs Advance with CTP-543 Phase 2a Topline Data in Alopecia Areata and CTP-692 Phase 1 Trial Initiation Expected in the Fourth Quarter of 2018

August 2, 2018
·
8 min read
Business

Spectrum Pharmaceuticals Announces Second Quarter 2018 Financial Results Teleconference and Webcast

Spectrum Pharmaceuticals announced it will host a teleconference and webcast with management to discuss the second quarter 2018 financial results, provide an update on the company’s business, and discuss expectations for the future on Thursday, August 9, 2018 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

August 2, 2018
·
3 min read
Business

Epizyme Reports Second Quarter 2018 Financial Results and Provides Business Updates

Conference Call to be Held Today at 8:30 a.m. ET

August 2, 2018
·
11 min read
Drug Development

Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

This second portion of our Phase 2 study should enable further demonstration of the accuracy of AVB-620 in distinguishing between malignant and nonmalignant tissues

August 2, 2018
·
2 min read
Business

Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs

Laura will serve as a member of Endo’s executive leadership team

August 2, 2018
·
3 min read